| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.7M | -1.9% |
| Cost of Revenue | $8.5M | -4.3% |
| Gross Profit | $7.2M | +1.2% |
| R&D Expense | $118K | -21.9% |
| SG&A Expense | $9.2M | -5.2% |
| Operating Income | -$2.2M | -165.2% |
| Pre-tax Income | -$2.4M | -177.6% |
| Income Tax | -$8K | -33.3% |
| Net Income | -$2.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $522K | +21.1% |
| Inventory | $4.9M | -13.4% |
| Current Assets | $6.2M | -21.4% |
| Total Assets | $7.9M | -13.8% |
| Current Liabilities | $6.1M | -0.1% |
| Total Liabilities | $6.1M | -2.6% |
| Stockholders' Equity | $1.8M | -38.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$861K | -138.2% |
| Capital Expenditures | $18K | — |
| Investing Cash Flow | -$28K | +82.1% |
| Financing Cash Flow | $32K | +102.3% |
| Free Cash Flow | -$879K | -139.0% |
| -177.2% |
| EPS (Basic) | -$0.01 | -150.0% |
| EPS (Diluted) | -$0.01 | -150.0% |